COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 1277: Articles 12761-12770  | Next

The Pandemic Brain: neuroinflammation in healthy, non-infected individuals during the COVID-19 pandemic
Brusaferri, L., Alshelh, Z., Martins, D., Kim, M., Weerasekera, A., Housman, H., Morrisey, E. J., Knight, P. C., Castro-Blanco, K. A., Albrecht, D. S., Tseng, C.-E., Zurcher, N. R., Ratai, E.-M., Johnson-Akeju, O., Mercaldo, N. D., Hadjikhani, N., Veronese, M., Turkheimer, F., Rosen, B. R., Hooker, J. M., Loggia, M. L.
10.1101/2021.09.21.21263740 — Posted: 2021-09-27
Using genomic epidemiology of SARS-CoV-2 to support contact tracing and public health surveillance in rural Humboldt County, California.
Stoddard, G., Black, A., Ayscue, P., Lu, D., Kamm, J., Bhatt, K., Chan, L., Kistler, A. L., Batson, J., Detweiler, A., Tan, M., Neff, N., DeRisi, J. L., Corrigan, J.
10.1101/2021.09.21.21258385 — Posted: 2021-09-27
Modeling the transmission of the SARS-CoV-2 delta variant in a partially vaccinated population
Avila, U., Avila, E., Huang, K.-l.
10.1101/2021.09.23.21264032 — Posted: 2021-09-26
SARS-CoV-2 vaccines breakthrough infection hospitalizations after one dose in Libya: cohort study
Abdelhamid, M. H. M., Al msellati, I. A., Annajar, B. B., Abdelhamid, A. H., alemam, H., Eltikar, M.
10.1101/2021.09.26.21263691 — Posted: 2021-09-26
Viroporin activity of SARS-CoV-2 Orf3a and Envelope protein impacts viral pathogenicity
Sarkar, M., Etheimer, P., Saha, S.
10.1101/2021.09.26.461873 — Posted: 2021-09-26
Deactivation of SARS-CoV-2 surrogate porcine epidemic diarrhea virus with electron beam irradiation under the cold chain transportation condition
Liu, Y., Shao, Y., Wang, L., Lu, W., Li, S., Xu, D., Fu, Y. V.
10.1101/2021.09.25.461766 — Posted: 2021-09-26
Cytotoxic T-cell-based vaccine against SARS-CoV2: a hybrid immunoinformatic approach
Tirziu, A., Paunescu, V.
10.1101/2021.09.26.461851 — Posted: 2021-09-26
Evaluation Of A New All In One Sars-Cov-2 Antigen-Detecting Rapid Diagnostic Test And Self-Test: Diagnostic Performance And Usability On Child And Adult Population
prazuck, t., Gravier, A., Pires-Roteira, D., Theillay, A., Pallay, S., Colin, M., Serreau, R., Hocqueloux, L., Cassuto, N. G.
10.1101/2021.09.14.21263403 — Posted: 2021-09-26
COVID-19 Vaccine Breakthrough Infections in the Veterans Health Administration.
Sharma, A., Oda, G., Holodniy, M.
10.1101/2021.09.23.21263864 — Posted: 2021-09-26 Discussion: Onsite
Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay
Kato, H., Miyakawa, K., Ohtake, N., Go, H., Yamaoka, Y., Yajima, S., Shimada, T., Goto, A., Nakajima, H., Ryo, A.
10.1101/2021.09.23.21263927 — Posted: 2021-09-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).